Skip to main content
Log in

Fidaxomicin cost effective for Clostridium difficile infections

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Burton HE, et al. A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection. PharmacoEconomics : 5 Sep 2017. Available from: URL: http://dx.doi.org/10.1007/s40273-017-0540-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fidaxomicin cost effective for Clostridium difficile infections. PharmacoEcon Outcomes News 787, 16 (2017). https://doi.org/10.1007/s40274-017-4344-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4344-6

Navigation